Clinical trial
Crossover Study With MultiHance vs a Comparator for Peripheral MRA
NCT00408083 · Bracco Diagnostics, Inc, Industry · Completed
Key facts
| NCT number | NCT00408083 |
|---|---|
| Title | Crossover Study With MultiHance vs a Comparator for Peripheral MRA |
| Official title | A Phase IIIB, Double-Blind, Multi-Center, Randomized, Cross-Over Study to Compare 0.1 Mmol/kg of Multihance With 0.1 Mmol/kg of Magnevist for Contrast-Enhanced Magnetic Resonance Angiography(CE-MRA) of Peripheral Arteries |
| Lead sponsor | Bracco Diagnostics, Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Peripheral Vascular Disease |
| Intervention type | Drug |
| Interventions | MultiHance, Magnevist |
| Enrollment | 100 |
| Start date | Dec 1, 2006 |
| Primary completion | Nov 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Dec 6, 2006 |
| Last update posted | Mar 27, 2009 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: